Coloplast B
Research Coloplast B (COLO-B.CO) on Bullrun: market cap DKK 95.67B, P/E 34.6, dividend yield 5.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCOLO-B.CO
- ExchangeXCSE
- CountryDenmark
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyDKK
- Market capDKK 95.67B
- P/E34.6
- Dividend yield5.0%
- Financial periodQ1 2026
- RevenueDKK 7.08B
- Net income-DKK 971.00M
- Free cash flowDKK 1.02B
- Gross margin66.6%
Valuation Snapshot
latest market cap is DKK 95.67B; P/E is 34.6; dividend yield is 5.0%.
Peer valuation comparison
Latest P/E is 34.62x versus a Healthcare sector median of 24.6x (40.8% above).
Latest dividend yield is 5.04% versus a Healthcare sector median of 1.84% (173.9% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | DKK 27.87B | DKK 3.64B | n/a | 68.0% | 16.13 | DKK 788.00M | DKK 11.96B | DKK 15.46B |
| FY2023 | DKK 27.03B | DKK 5.05B | n/a | 67.6% | 22.46 | DKK 911.00M | DKK 4.83B | DKK 17.30B |
| FY2022 | DKK 24.50B | DKK 4.78B | n/a | 66.6% | 22.2 | DKK 414.00M | DKK 4.39B | DKK 8.29B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-08 | DKK 95.67B | 34.6 | 5.4% | 23 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 23 DKK, yield 5.0%.
| Year | Dividends/share |
|---|---|
| FY2025 | 3.07 DKK |
| FY2024 | 2.94 DKK |
| FY2023 | 2.81 DKK |
| FY2022 | 2.67 DKK |
About Coloplast B
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Coloplast B's market cap?
Coloplast B's market capitalization is DKK 95.67B.
What is Coloplast B's P/E ratio?
Coloplast B's price-to-earnings (P/E) ratio is 34.6.
Does Coloplast B pay a dividend?
Coloplast B has a dividend yield of 5.0%.
What does Coloplast B do?
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.